WO2024198078A1 - Amino acid derivative, preparation method therefor, and method for synthesizing l-glufosinate ammonium using amino acid derivative as intermediate - Google Patents
Amino acid derivative, preparation method therefor, and method for synthesizing l-glufosinate ammonium using amino acid derivative as intermediate Download PDFInfo
- Publication number
- WO2024198078A1 WO2024198078A1 PCT/CN2023/097690 CN2023097690W WO2024198078A1 WO 2024198078 A1 WO2024198078 A1 WO 2024198078A1 CN 2023097690 W CN2023097690 W CN 2023097690W WO 2024198078 A1 WO2024198078 A1 WO 2024198078A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- carbon atoms
- acid
- glufosinate
- preparing
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 150000003862 amino acid derivatives Chemical class 0.000 title abstract description 6
- 230000002194 synthesizing effect Effects 0.000 title abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 12
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000006482 condensation reaction Methods 0.000 claims abstract description 5
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 6
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- 238000006555 catalytic reaction Methods 0.000 claims description 5
- -1 4-(2-hydroxyethyl)-5-oxooxazolidine-3-carboxylate Chemical compound 0.000 claims description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 4
- 125000001072 heteroaryl group Chemical group 0.000 claims description 4
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 claims description 4
- 239000000126 substance Chemical group 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 2
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 claims description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000002585 base Substances 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 229940117389 dichlorobenzene Drugs 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 2
- 229940071870 hydroiodic acid Drugs 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 abstract description 12
- 230000003287 optical effect Effects 0.000 abstract description 6
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 230000036632 reaction speed Effects 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- UTZAXPKCGJZGLB-UHFFFAOYSA-N diethyl methyl phosphite Chemical compound CCOP(OC)OCC UTZAXPKCGJZGLB-UHFFFAOYSA-N 0.000 description 6
- 239000005561 Glufosinate Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000005292 vacuum distillation Methods 0.000 description 3
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 229930195722 L-methionine Natural products 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- OJYIPVKINQFIME-UHFFFAOYSA-N CCCCOP(C)(O)O Chemical compound CCCCOP(C)(O)O OJYIPVKINQFIME-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- PVAFTPFFPGLNRV-UHFFFAOYSA-N Cl.O=C1CCCO1 Chemical compound Cl.O=C1CCCO1 PVAFTPFFPGLNRV-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000004648 butanoic acid derivatives Chemical class 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- UFZOPKFMKMAWLU-UHFFFAOYSA-M ethoxy(methyl)phosphinate Chemical compound CCOP(C)([O-])=O UFZOPKFMKMAWLU-UHFFFAOYSA-M 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P13/00—Herbicides; Algicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/32—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D2101/00—Harmful chemical substances made harmless, or less harmful, by effecting chemical change
- A62D2101/04—Pesticides, e.g. insecticides, herbicides, fungicides or nematocides
Definitions
- the invention belongs to the technical field of synthesis of organic matter and its intermediates, and specifically relates to an amino acid derivative and a preparation method thereof, and a method for synthesizing L-glufosinate as a chiral intermediate.
- Glufosinate ammonium is a broad-spectrum contact herbicide developed by the former German company AIGFO (later owned by Bayer) in the 1980s.
- Glufosinate contains a chiral center and has two optical isomers, L and D, but only L-glufosinate has herbicidal activity.
- glufosinate ammonium at home and abroad can be summarized into two types: one is biological fermentation method, and the other is chemical synthesis method. At present, its manufacturing adopts chemical synthesis method, and biological fermentation method is still a long way from industrial production.
- Chinese patent CN113316580 uses halogenated butyrate or butyrolactone to react with diethyl methylphosphite, but the reaction yield is between 60-65%, which is still relatively low for industrial production and still needs further improvement.
- Chinese patent CN202011270812 provides a high-efficiency, high-yield, and low-cost production process for L-homoserine, making it possible to synthesize L-glufosinate from the chiral raw material L-homoserine.
- the present invention provides a new method for synthesizing L-phosphinothricin from L-homoserine.
- the synthesis method has a short route, high yield, high optical purity and low cost.
- the object of the present invention is to provide an L-homoserine derivative (Compound I) and a method for preparing L-glufosinate-ammonium with high optical purity in a simple and high yield.
- One aspect of the present invention provides a compound I, which is a homoserine derivative, and its chemical structure is as follows:
- R1 is hydrogen, a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 10 carbon atoms, or phenyl, p-tolyl, or p-nitrophenyl;
- R2 is hydrogen, substituted or unsubstituted alkyl having 1 to 6 carbon atoms, substituted or unsubstituted alkenyl having 1 to 6 carbon atoms, substituted or unsubstituted alkynyl having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 10 carbon atoms, or substituted or unsubstituted aryl having 6 to 20 carbon atoms, substituted or unsubstituted heteroaryl having 2 to 10 carbon atoms;
- the substituents of the alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl groups are independently selected from at least one group consisting of hydrogen, halogen, carboxyl, amino, nitro, cyano, alkyl groups having 1 to 6 carbon atoms, aryl groups having 6 to 10 carbon atoms and cycloalkyl groups having 3 to 10 carbon atoms.
- Another aspect of the present invention also provides a method for preparing compound I, which comprises the following steps: dissolving 4-(2-hydroxyethyl)-5-oxooxazolidine-3-carboxylate in a suitable solvent, adding sulfonyl chloride dropwise under the catalysis of a base, and then washing with alkali, washing with water, drying, and concentrating to obtain compound I;
- the solvent comprises dichloromethane, chloroform, DMF, DMSO, ethyl acetate, toluene, xylene, cyclohexane, acetonitrile, ethanol, isopropanol, and methanol.
- Another aspect of the present invention also provides a method for preparing L-glufosinate ammonium, which is prepared using the above-mentioned compound I or the compound I obtained according to the above-mentioned preparation method as a raw material, and the preparation method comprises the following steps:
- step S1 is methylphosphite, and its structural formula is as follows:
- R3 is methyl, ethyl, propyl, isopropyl, n-butyl, tert-butyl.
- the compound II is any one selected from the group consisting of diethyl methylphosphite, ethyl methylphosphite and butyl methylphosphite.
- step S1 the amount ratio of compound I to compound II is 1:1-100.
- step S1 the solvent is added in a mass ratio of 0.1-100:1 to compound I, preferably, the mass ratio is 5-10:1.
- the solvent in step S1 is at least one selected from the group consisting of ethyl formate, ethyl acetate, methanol, ethanol, isopropanol, benzene, toluene, chlorobenzene, dichlorobenzene, nitrobenzene, dichloroethane, chloroform, DMSO, DMF, HMPA, and compound II.
- condensation reaction conditions in step S1 are: temperature 20-200° C., preferably 80-150° C., most preferably 90-110° C.; time 1-24 h, preferably 3-12 h, most preferably 6-8 h.
- the acid in step S2 is at least one selected from the group consisting of acetic acid, trifluoroacetic acid, trifluoromethanesulfonic acid, hydrochloric acid, sulfuric acid, methanesulfonic acid, phosphoric acid, hydrofluoric acid, hydrobromic acid and hydroiodic acid.
- step S2 the hydrolysis conditions in step S2 are: temperature 60-180° C., time 0.5-24 h.
- the L-glufosinate is selected from at least one of the hydrochloride of L-glufosinate, the sulfate of L-glufosinate, the carbonate of L-glufosinate, the sodium salt of L-glufosinate and the ammonium salt of L-glufosinate.
- the method for preparing L-glufosinate-ammonium of the present invention can simply produce L-glufosinate-ammonium with high optical purity by using a new intermediate compound I and having a new synthetic route.
- the present invention uses homoserine as a starting material, activates the ⁇ -hydroxyl group, and then condenses it with phosphite to introduce a phosphite group, and finally undergoes acid hydrolysis, neutralization, etc. to obtain the target end product.
- the present invention has high reaction activity between the active intermediate and the phosphite, fast raw material conversion speed and high conversion rate, and the amount of phosphite used is much lower than that of the existing process, so the production cost is much lower than that of the existing technology.
- the preparation method of the present invention has a wide range of applications, and similar compounds can be synthesized using this method, which has great industrial and commercial value.
- L-glufosinate was subjected to nuclear magnetic resonance analysis, and its nuclear magnetic data (HNMR, D2O, 500MHz) were obtained: ⁇ ppm3.70 ⁇ 3.75(1H, t, CH), 2.00 ⁇ 2.05(2H, m, CH2), 1.50 ⁇ 1.60(2H, m, CH2), 1.14 ⁇ 1.21(3H, d, CH3).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
Abstract
Disclosed are an amino acid derivative, a preparation method therefor, and a method for synthesizing L-glufosinate ammonium using the amino acid derivative as an intermediate. The derivative is obtained from L-homoserine by means of a conventional chemical reaction. The method for preparing glufosinate ammonium, particularly L-glufosinate ammonium, using the derivative comprises the following steps: conducting a condensation reaction on the amino acid derivative (compound (I)) and methyl phosphite in a proper solvent to obtain compound (II), and further hydrolyzing and salifying the compound II to obtain the glufosinate ammonium. The preparation method of the present invention features a high reaction speed and a high raw material conversion rate, the obtained product has a high optical rotation purity, and the raw materials used are cheap and readily available, such that the preparation method is very suitable for scale production.
Description
本发明属于有机物及其中间体合成技术领域,具体而言,涉及一种氨基酸衍生物及其制备方法和作为手性中间体合成L-草铵膦的方法。The invention belongs to the technical field of synthesis of organic matter and its intermediates, and specifically relates to an amino acid derivative and a preparation method thereof, and a method for synthesizing L-glufosinate as a chiral intermediate.
草铵膦(glufosinate ammonium,phosphinothricin)是由原德国艾格福公司(后归属拜耳公司)在20世纪80年代开发成功的一种广谱触杀型灭生性除草剂。Glufosinate ammonium (phosphinothricin) is a broad-spectrum contact herbicide developed by the former German company AIGFO (later owned by Bayer) in the 1980s.
草铵膦含有一个手性中心,具有L型和D型两种光学异构体,但只有L-草铵膦具有除草活性。目前上市的草铵膦除草剂主要为D:L=1:1的外消旋产品,若草铵膦产品中只含有L-构型的光学异构体,理论上单亩草铵膦使用量可以降低50%,这对于降低使用农药成本,减轻环境压力均有十分重要的意义。L-草铵膦因此成为了草铵膦行业重要的发展趋势之一。
Glufosinate contains a chiral center and has two optical isomers, L and D, but only L-glufosinate has herbicidal activity. Currently, the glufosinate herbicides on the market are mainly racemic products with a D:L=1:1 ratio. If the glufosinate product only contains the L-configuration optical isomer, the theoretical amount of glufosinate used per acre can be reduced by 50%, which is of great significance for reducing the cost of using pesticides and alleviating environmental pressure. L-glufosinate has therefore become one of the important development trends of the glufosinate industry.
Glufosinate contains a chiral center and has two optical isomers, L and D, but only L-glufosinate has herbicidal activity. Currently, the glufosinate herbicides on the market are mainly racemic products with a D:L=1:1 ratio. If the glufosinate product only contains the L-configuration optical isomer, the theoretical amount of glufosinate used per acre can be reduced by 50%, which is of great significance for reducing the cost of using pesticides and alleviating environmental pressure. L-glufosinate has therefore become one of the important development trends of the glufosinate industry.
目前国内外草铵膦的合成方法可归纳为二种:其一为生物发酵法,其二为化学合成法。目前,其制造均采用的是化学合成法,生物发酵法距离可工业化生产还有一大段距离。At present, the synthesis methods of glufosinate ammonium at home and abroad can be summarized into two types: one is biological fermentation method, and the other is chemical synthesis method. At present, its manufacturing adopts chemical synthesis method, and biological fermentation method is still a long way from industrial production.
中国专利CN106083922以及Chinese Chemical Letters Vol.17,No.2,pp177-179,2006以天然氨基酸L-蛋氨酸为起始物料,经过过甲基化、水解、环等步骤合成γ-丁内酯盐酸盐,再经保护、开环、阿布佐夫、水解等反应得到L-草铵膦。但是,其起始原料L-蛋氨酸价格较高,且反应步骤较长,工艺中三废多,该路线成本极高,很难实现产业化。
Chinese patent CN106083922 and Chinese Chemical Letters Vol.17, No.2, pp177-179, 2006 use natural amino acid L-methionine as the starting material, synthesize γ-butyrolactone hydrochloride through methylation, hydrolysis, cyclization and other steps, and then obtain L-phosphinothricin ammonium through protection, ring opening, absolv, hydrolysis and other reactions. However, the starting material L-methionine is relatively expensive, the reaction steps are relatively long, and there are many three wastes in the process. The cost of this route is extremely high and it is difficult to achieve industrialization.
Chinese patent CN106083922 and Chinese Chemical Letters Vol.17, No.2, pp177-179, 2006 use natural amino acid L-methionine as the starting material, synthesize γ-butyrolactone hydrochloride through methylation, hydrolysis, cyclization and other steps, and then obtain L-phosphinothricin ammonium through protection, ring opening, absolv, hydrolysis and other reactions. However, the starting material L-methionine is relatively expensive, the reaction steps are relatively long, and there are many three wastes in the process. The cost of this route is extremely high and it is difficult to achieve industrialization.
在《化学法合成精草铵膦的研究进展》一文综述了化学法制备草铵膦的几种方法,即手性辅助试剂法、天然氨基酸手性源法及不对称催化法。这些方法缺点十分明显,手性辅助试剂法及不对称催化法需要用到昂贵的催化剂,无疑增加了成本,尤其不对称催化法用到的金属催化剂具有一定环境危害性,增加环保压力,而天然氨基酸手性源法大部分采用的路线都较长、或收率较低,而且工艺繁琐。In the article "Research Progress of Chemical Synthesis of Glufosinate-ammonium", several methods for preparing glufosinate-ammonium by chemical method are reviewed, namely chiral auxiliary reagent method, natural amino acid chiral source method and asymmetric catalysis method. These methods have obvious disadvantages. The chiral auxiliary reagent method and asymmetric catalysis method require expensive catalysts, which undoubtedly increases the cost. In particular, the metal catalysts used in the asymmetric catalysis method have certain environmental hazards, which increases the pressure on environmental protection. Most of the routes used in the natural amino acid chiral source method are long or have low yields, and the process is cumbersome.
中国专利CN113316580采用卤代丁酸酯或丁内酯与甲基亚磷酸二乙酯反应,但反应收率均在60-65%之间,对于工业化生产来说这个值还是比较低,仍需要进一步改进提升。Chinese patent CN113316580 uses halogenated butyrate or butyrolactone to react with diethyl methylphosphite, but the reaction yield is between 60-65%, which is still relatively low for industrial production and still needs further improvement.
中国专利CN202011270812提供了一种L-高丝氨酸高效高产、低成本的生产工艺,使得以手性原料L-高丝氨酸合成L-草铵膦成为可能。Chinese patent CN202011270812 provides a high-efficiency, high-yield, and low-cost production process for L-homoserine, making it possible to synthesize L-glufosinate from the chiral raw material L-homoserine.
为克服上述L草铵膦合成技术的缺点,本发明提供了一种以L-高丝氨酸合成L-草铵膦的合成新方法,该合成方法路线短、收率高、光学纯度高,成本低。In order to overcome the shortcomings of the above-mentioned L-phosphinothricin synthesis technology, the present invention provides a new method for synthesizing L-phosphinothricin from L-homoserine. The synthesis method has a short route, high yield, high optical purity and low cost.
发明内容Summary of the invention
本发明的目的是提供一种L-高丝氨酸衍生物(化合物I),及其简单高收率地制备具有高光学纯度的L-草铵膦的方法。The object of the present invention is to provide an L-homoserine derivative (Compound I) and a method for preparing L-glufosinate-ammonium with high optical purity in a simple and high yield.
本发明的目的及解决其技术问题是采用以下技术方案来实现的。The purpose of the present invention and the solution to the technical problem are achieved by adopting the following technical solutions.
本发明的一个方面提供了一种化合物I,所述化合物I为高丝氨酸衍生物,其化学结构通式如下:
One aspect of the present invention provides a compound I, which is a homoserine derivative, and its chemical structure is as follows:
One aspect of the present invention provides a compound I, which is a homoserine derivative, and its chemical structure is as follows:
其中,R1是氢、取代或未经取代的具有1至6个碳原子的烷基、取代或未经取代的具有3至10个碳原子的环烷基、或苯基、对甲苯基、对硝基苯基;wherein R1 is hydrogen, a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 10 carbon atoms, or phenyl, p-tolyl, or p-nitrophenyl;
R2是氢、取代或未经取代的具有1至6个碳原子的烷基、取代或未经取代的具有1至6个碳原子的烯基、取代或未经取代的具有1至6个碳原子的炔基、取代或未经取代的具有3至10个碳原子的环烷基、或取代或未经取代的具有6至20个碳原子的芳基、取代或未经取代的具有2至10个碳原子的杂芳基; R2 is hydrogen, substituted or unsubstituted alkyl having 1 to 6 carbon atoms, substituted or unsubstituted alkenyl having 1 to 6 carbon atoms, substituted or unsubstituted alkynyl having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 10 carbon atoms, or substituted or unsubstituted aryl having 6 to 20 carbon atoms, substituted or unsubstituted heteroaryl having 2 to 10 carbon atoms;
所述烷基、烯基、炔基、环烷基、芳基和杂芳基的取代基彼此独立地为选自由氢、卤素、羧基、氨基、硝基、氰基、具有1至6个碳原子的烷基、具有6至10个碳原子的芳基和具有3至10个碳原子的环烷基组成的组中的至少一种。The substituents of the alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl groups are independently selected from at least one group consisting of hydrogen, halogen, carboxyl, amino, nitro, cyano, alkyl groups having 1 to 6 carbon atoms, aryl groups having 6 to 10 carbon atoms and cycloalkyl groups having 3 to 10 carbon atoms.
本发明的另一个方面还提供了一种化合物I的制备方法,所述方法包括以下步骤:将4-(2-羟乙基)-5-氧代恶唑烷-3-羧酸酯溶于合适的溶剂中,在碱的催化下,滴加磺酰氯,再经过碱洗、水洗、干燥、浓缩,即得化合物I;所述溶剂包括二氯甲烷、氯仿、DMF、DMSO、乙酸乙酯、甲苯、二甲苯、环己烷、乙腈、乙醇、异丙醇、甲醇。Another aspect of the present invention also provides a method for preparing compound I, which comprises the following steps: dissolving 4-(2-hydroxyethyl)-5-oxooxazolidine-3-carboxylate in a suitable solvent, adding sulfonyl chloride dropwise under the catalysis of a base, and then washing with alkali, washing with water, drying, and concentrating to obtain compound I; the solvent comprises dichloromethane, chloroform, DMF, DMSO, ethyl acetate, toluene, xylene, cyclohexane, acetonitrile, ethanol, isopropanol, and methanol.
本发明的又一个方面还提供一种L-草铵膦的制备方法,在于使用上述的化合物I或者根据上述的制备方法得到的化合物I为原料进行制备得到,所述制备方法包括如下步骤:Another aspect of the present invention also provides a method for preparing L-glufosinate ammonium, which is prepared using the above-mentioned compound I or the compound I obtained according to the above-mentioned preparation method as a raw material, and the preparation method comprises the following steps:
S1:将化合物I与化合物II按照一定比例,在合适的溶剂下进行缩合反应得到化合物III,其化学反应式为:
S1: Compound I and compound II are subjected to condensation reaction in a certain ratio in a suitable solvent to obtain compound III, the chemical reaction formula of which is:
S1: Compound I and compound II are subjected to condensation reaction in a certain ratio in a suitable solvent to obtain compound III, the chemical reaction formula of which is:
S2:将上述得到的化合物III在酸存在下经过水解脱保护基而制得L-草铵膦,其化学反应式为:
S2: The compound III obtained above is subjected to hydrolysis in the presence of an acid to deprotect the group to obtain L-phosphinothricin ammonium, and the chemical reaction formula is:
S2: The compound III obtained above is subjected to hydrolysis in the presence of an acid to deprotect the group to obtain L-phosphinothricin ammonium, and the chemical reaction formula is:
进一步地,步骤S1中所述化合物II为甲亚磷酸酯,其结构式如下:
Furthermore, the compound II in step S1 is methylphosphite, and its structural formula is as follows:
Furthermore, the compound II in step S1 is methylphosphite, and its structural formula is as follows:
其中,R3为甲基,乙基,丙基,异丙基,正丁基,叔丁基。Among them, R3 is methyl, ethyl, propyl, isopropyl, n-butyl, tert-butyl.
进一步地,所述化合物II选自由甲基亚膦酸二乙酯、甲基亚膦酸乙酯和甲基亚膦酸丁酯组成的组中的任一种。Further, the compound II is any one selected from the group consisting of diethyl methylphosphite, ethyl methylphosphite and butyl methylphosphite.
进一步地,步骤S1中所述化合物I和化合物II的物质量比为1:1-100。Furthermore, in step S1, the amount ratio of compound I to compound II is 1:1-100.
进一步地,步骤S1中所述溶剂按照与化合物I的质量比为0.1-100:1加入,优选地,质量比为5-10:1。Furthermore, in step S1, the solvent is added in a mass ratio of 0.1-100:1 to compound I, preferably, the mass ratio is 5-10:1.
进一步地,步骤S1中所述溶剂选自由甲酸乙酯、乙酸乙酯、甲醇、乙醇、异丙醇、苯、甲苯、氯苯、二氯苯、硝基苯、二氯乙烷、氯仿、DMSO、DMF、HMPA、化合物II组成的组中的至少一种。Furthermore, the solvent in step S1 is at least one selected from the group consisting of ethyl formate, ethyl acetate, methanol, ethanol, isopropanol, benzene, toluene, chlorobenzene, dichlorobenzene, nitrobenzene, dichloroethane, chloroform, DMSO, DMF, HMPA, and compound II.
进一步地,步骤S1中所述缩合反应条件为:温度20~200℃,优选80-150℃,最优选90-110℃;时间1~24h,优选3-12h,最优选6-8h。Furthermore, the condensation reaction conditions in step S1 are: temperature 20-200° C., preferably 80-150° C., most preferably 90-110° C.; time 1-24 h, preferably 3-12 h, most preferably 6-8 h.
进一步地,步骤S2中所述酸选自由乙酸、三氟乙酸、三氟甲磺酸、盐酸、硫酸、甲磺酸、磷酸、氢氟酸、氢溴酸和氢碘酸组成的组中的至少一种。Furthermore, the acid in step S2 is at least one selected from the group consisting of acetic acid, trifluoroacetic acid, trifluoromethanesulfonic acid, hydrochloric acid, sulfuric acid, methanesulfonic acid, phosphoric acid, hydrofluoric acid, hydrobromic acid and hydroiodic acid.
进一步地,步骤S2中所述水解条件为:温度60-180℃,时间0.5-24h。
Furthermore, the hydrolysis conditions in step S2 are: temperature 60-180° C., time 0.5-24 h.
进一步地,所述L-草铵膦选自L-草铵膦的盐酸盐、L-草铵膦的硫酸盐、L-草铵膦的碳酸盐、L-草铵膦的钠盐和L-草铵膦的铵盐中的至少一种。Furthermore, the L-glufosinate is selected from at least one of the hydrochloride of L-glufosinate, the sulfate of L-glufosinate, the carbonate of L-glufosinate, the sodium salt of L-glufosinate and the ammonium salt of L-glufosinate.
发明预期效果与优点如下:The expected effects and advantages of the invention are as follows:
1)本发明的L-草铵膦的制备方法能够通过使用新的中间体化合物I和具备新的合成路线而简单地制造具有高光学纯度的L-草铵膦。1) The method for preparing L-glufosinate-ammonium of the present invention can simply produce L-glufosinate-ammonium with high optical purity by using a new intermediate compound I and having a new synthetic route.
2)本发明以高丝氨酸为起始物,对γ-羟基进行活化,再与亚磷酸酯缩合引入磷酯基团,最后经过酸解、中和等,得到目标终产物。2) The present invention uses homoserine as a starting material, activates the γ-hydroxyl group, and then condenses it with phosphite to introduce a phosphite group, and finally undergoes acid hydrolysis, neutralization, etc. to obtain the target end product.
3)本发明以活性中间体与亚磷酸酯的反应活性高,原料转化速度快且转化率高,亚磷酸酯用量远低于现有工艺,因此生产成本远低于现有技术的方案。3) The present invention has high reaction activity between the active intermediate and the phosphite, fast raw material conversion speed and high conversion rate, and the amount of phosphite used is much lower than that of the existing process, so the production cost is much lower than that of the existing technology.
4)本发明的制备方法所使用的原材料均廉价易得,可有效降低成本。4) The raw materials used in the preparation method of the present invention are cheap and easily available, which can effectively reduce the cost.
5)本发明的制备方法中溶剂大部分为水或底物本身,具有节能环保方面良好的社会效益。5) In the preparation method of the present invention, most of the solvent is water or the substrate itself, which has good social benefits in terms of energy saving and environmental protection.
6)本发明的制备方法使用范围广,类似化合物都可使用此方法合成,具有较大的工业化及商业化价值。6) The preparation method of the present invention has a wide range of applications, and similar compounds can be synthesized using this method, which has great industrial and commercial value.
上述说明仅是本发明技术方案的概述,为了能够更清楚了解本发明的技术手段,并可依照说明书的内容予以实施,以下以本发明的较佳实施例详细说明如后。The above description is only an overview of the technical solution of the present invention. In order to more clearly understand the technical means of the present invention and implement it according to the contents of the specification, the preferred embodiments of the present invention are described in detail as follows.
为了使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解,下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。In order to make the technical means, creative features, objectives and effects of the present invention easy to understand, the technical solutions in the embodiments of the present invention will be clearly and completely described below in combination with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
实施例1 L-草铵膦的制备
Example 1 Preparation of L-phosphinothricin
本实施例中L-草铵膦的制备方法如下:
The preparation method of L-phosphinothion in this embodiment is as follows:
The preparation method of L-phosphinothion in this embodiment is as follows:
1)向反应瓶中一次性依次加入4-(2-甲磺酰氧乙基)-5-氧代恶唑烷-3-羧酸甲酯5.0g,甲基亚磷酸酯二乙酯50ml,通入氮气置换体系2次并保持氮气氛,升温至90℃反应6h,TLC检测反应完成,浓缩至干,柱层析分离,干得淡黄色油状物,收率为90.7%。1) 5.0 g of methyl 4-(2-methylsulfonyloxyethyl)-5-oxooxazolidine-3-carboxylate and 50 ml of diethyl methyl phosphite were added to the reaction flask in sequence, and nitrogen was introduced into the system twice while maintaining the nitrogen atmosphere. The temperature was raised to 90° C. and the reaction was carried out for 6 h. The reaction was completed after TLC detection. The mixture was concentrated to dryness and separated by column chromatography to obtain a light yellow oil with a yield of 90.7%.
2)向反应瓶中一次性依次加入以上油状物4.5g,浓度为6mol/L的盐酸45ml,然后加热至120℃回流反应8h,反应完成后,减压蒸馏浓缩至干,加入乙醇,搅拌析出固体,抽滤、干燥,收率为91.2%;ee%值98.9%。2) 4.5 g of the above oil and 45 ml of 6 mol/L hydrochloric acid were added to the reaction flask in sequence, and then heated to 120°C for reflux reaction for 8 h. After the reaction was completed, the mixture was concentrated to dryness by vacuum distillation, ethanol was added, and the solid was precipitated by stirring, filtered and dried. The yield was 91.2% and the ee% value was 98.9%.
对得到的L-草铵膦进行核磁分析,得到其核磁数据(HNMR,D2O,500MHz):δppm3.70~3.75(1H,t,CH),2.00~2.05(2H,m,CH2),1.50~1.60(2H,m,CH2),1.14~1.21(3H,d,CH3)。The obtained L-glufosinate was subjected to nuclear magnetic resonance analysis, and its nuclear magnetic data (HNMR, D2O, 500MHz) were obtained: δppm3.70~3.75(1H, t, CH), 2.00~2.05(2H, m, CH2), 1.50~1.60(2H, m, CH2), 1.14~1.21(3H, d, CH3).
实施例2 L-草铵膦的制备Example 2 Preparation of L-phosphinothricin
本实施例中L-草铵膦的制备方法如下:
The preparation method of L-phosphinothion in this embodiment is as follows:
The preparation method of L-phosphinothion in this embodiment is as follows:
1)向反应瓶中一次性依次加入4-(2-甲磺酰氧乙基)-5-氧代恶唑烷-3-羧酸叔丁酯5.0g,甲基亚磷酸酯二乙酯20ml,甲苯100mL,氮气保护下,升温至90℃反应6h,TLC检测反应完成,浓缩至干,柱层析分离,干得淡黄色油状物,收率为98.7%。该过程的反应式为:1) 5.0 g of tert-butyl 4-(2-methylsulfonyloxyethyl)-5-oxoxazolidine-3-carboxylate, 20 ml of diethyl methylphosphite, and 100 ml of toluene were added to the reaction flask in sequence. Under nitrogen protection, the temperature was raised to 90° C. for 6 h. The reaction was completed by TLC detection. The mixture was concentrated to dryness and separated by column chromatography to obtain a light yellow oil with a yield of 98.7%. The reaction formula of the process is:
2)向反应瓶中一次性依次加入以上油状物4.5g,浓度为6mol/L的盐酸45ml,然后加热至120℃回流反应8h,反应完成后,减压蒸馏浓缩至干,加入乙醇,搅拌析出固体,抽滤、干燥,收率为92.8%;ee%值98.3%。2) 4.5 g of the above oil and 45 ml of 6 mol/L hydrochloric acid were added to the reaction flask in sequence, and then heated to 120°C for reflux reaction for 8 h. After the reaction was completed, the mixture was concentrated to dryness by vacuum distillation, ethanol was added, and the solid was precipitated by stirring, filtered and dried. The yield was 92.8% and the ee% value was 98.3%.
实施例3 L-草铵膦的制备
Example 3 Preparation of L-phosphinothricin
本实施例中L-草铵膦的制备方法如下:
The preparation method of L-phosphinothion in this embodiment is as follows:
The preparation method of L-phosphinothion in this embodiment is as follows:
1)向反应瓶中一次性依次加入4-(2-对硝基苯磺酰氧乙基)-5-氧代恶唑烷-3-羧酸叔丁酯5.0g,甲基亚磷酸酯二乙酯30ml,氯苯150mL,氮气保护下,升温至90℃反应6h,TLC检测反应完成,浓缩至干,柱层析分离,干得淡黄色油状物,收率为98.7%。该过程的反应式为:1) 5.0 g of tert-butyl 4-(2-p-nitrobenzenesulfonyloxyethyl)-5-oxoxazolidine-3-carboxylate, 30 ml of diethyl methylphosphite, and 150 ml of chlorobenzene were added to the reaction flask in sequence. Under nitrogen protection, the temperature was raised to 90° C. for 6 h. The reaction was completed after TLC detection. The mixture was concentrated to dryness and separated by column chromatography to obtain a light yellow oil with a yield of 98.7%. The reaction formula of the process is:
2)向反应瓶中一次性依次加入以上油状物4.5g,浓度为6mol/L的盐酸45ml,然后加热至流反应8h,反应完成后,减压蒸馏浓缩至干,加入乙醇,搅拌析出固体,抽滤、干燥,收率为97.0%;ee%值98.9%。2) Add 4.5 g of the above oil and 45 ml of 6 mol/L hydrochloric acid to the reaction flask at once, and then heat to The reaction was continued for 8 hours. After the reaction was completed, the mixture was concentrated to dryness by distillation under reduced pressure. Ethanol was added and stirred to precipitate solids, which were filtered and dried. The yield was 97.0% and the ee% value was 98.9%.
实施例4 L-草铵膦的制备Example 4 Preparation of L-phosphinothricin
本实施例中L-草铵膦的制备方法如下:
The preparation method of L-phosphinothion in this embodiment is as follows:
The preparation method of L-phosphinothion in this embodiment is as follows:
1)向反应瓶中一次性依次加入4-(2-甲磺酰氧乙基)-5-氧代恶唑烷-3-羧酸乙酯5.0g,甲基亚磷酸酯二乙酯50ml,氮气保护下,升温至90℃反应6h,TLC检测反应完成,浓缩至干,柱层析分离,干得淡黄色油状物,收率为93.7%。1) 5.0 g of ethyl 4-(2-methylsulfonyloxyethyl)-5-oxooxazolidine-3-carboxylate and 50 ml of diethyl methylphosphite were added to the reaction flask in sequence. Under nitrogen protection, the temperature was raised to 90° C. for reaction for 6 h. The reaction was completed after TLC detection. The mixture was concentrated to dryness and separated by column chromatography to obtain a light yellow oil with a yield of 93.7%.
2)向反应瓶中一次性依次加入以上油状物4.5g,浓度为6mol/L的盐酸45ml,然后加热至120℃回流反应8h,反应完成后,减压蒸馏浓缩至干,加入乙醇,搅拌析出固体,抽滤、干燥,收率为89.9%;ee%值99.5%。2) 4.5 g of the above oil and 45 ml of 6 mol/L hydrochloric acid were added to the reaction flask in sequence, and then heated to 120°C for reflux reaction for 8 h. After the reaction was completed, the mixture was concentrated to dryness by vacuum distillation, ethanol was added, and the solid was precipitated by stirring, filtered and dried. The yield was 89.9% and the ee% value was 99.5%.
以上所述,仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,虽然本发明已以较佳实施例揭露如上,然而并非用以限定本发明,任何熟悉本专业的技术人员,在不脱离本发明技术方案范围内,当可利用上述揭示的方法及技术内容作出些许的更动或修饰为等同变化的等效实施例,但凡是未脱离本发明技术方案的内容,依据本
发明的技术实质对以上实施例所作的任何简单修改、等同变化与修饰,均仍属于本发明技术方案的范围内。
The above is only a preferred embodiment of the present invention, and does not limit the present invention in any form. Although the present invention has been disclosed as a preferred embodiment, it is not used to limit the present invention. Any technician familiar with the profession can make some changes or modifications to equivalent embodiments of equivalent changes using the methods and technical contents disclosed above without departing from the scope of the technical solution of the present invention. However, all contents that do not depart from the technical solution of the present invention are based on this invention. Any simple modification, equivalent changes and modifications made to the above embodiments by the technical essence of the invention still fall within the scope of the technical solution of the present invention.
Claims (10)
- 化合物I,其特征在于,所述化合物I为高丝氨酸衍生物,其化学结构通式如下:
Compound I, characterized in that the compound I is a homoserine derivative, and its chemical structure formula is as follows:
其中,R1是氢、取代或未经取代的具有1至6个碳原子的烷基、取代或未经取代的具有3至10个碳原子的环烷基、或苯基、对甲苯基、对硝基苯基;wherein R1 is hydrogen, a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 10 carbon atoms, or phenyl, p-tolyl, or p-nitrophenyl;R2是氢、取代或未经取代的具有1至6个碳原子的烷基、取代或未经取代的具有1至6个碳原子的烯基、取代或未经取代的具有1至6个碳原子的炔基、取代或未经取代的具有3至10个碳原子的环烷基、或取代或未经取代的具有6至20个碳原子的芳基、取代或未经取代的具有2至10个碳原子的杂芳基; R2 is hydrogen, substituted or unsubstituted alkyl having 1 to 6 carbon atoms, substituted or unsubstituted alkenyl having 1 to 6 carbon atoms, substituted or unsubstituted alkynyl having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 10 carbon atoms, or substituted or unsubstituted aryl having 6 to 20 carbon atoms, substituted or unsubstituted heteroaryl having 2 to 10 carbon atoms;所述烷基、烯基、炔基、环烷基、芳基和杂芳基的取代基彼此独立地为选自由氢、卤素、羧基、氨基、硝基、氰基、具有1至6个碳原子的烷基、具有6至10个碳原子的芳基和具有3至10个碳原子的环烷基组成的组中的至少一种。The substituents of the alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl groups are independently selected from at least one group consisting of hydrogen, halogen, carboxyl, amino, nitro, cyano, alkyl groups having 1 to 6 carbon atoms, aryl groups having 6 to 10 carbon atoms and cycloalkyl groups having 3 to 10 carbon atoms. - 根据权利要求1所述的化合物I的制备方法,其特征在于,所述方法包括以下步骤:将4-(2-羟乙基)-5-氧代恶唑烷-3-羧酸酯溶于合适的溶剂中,在碱的催化下,滴加磺酰氯,再经过碱洗、水洗、干燥、浓缩,即得化合物I;所述溶剂包括二氯甲烷、氯仿、DMF、DMSO、乙酸乙酯、甲苯、二甲苯、环己烷、乙腈、乙醇、异丙醇、甲醇。The method for preparing compound I according to claim 1, characterized in that the method comprises the following steps: dissolving 4-(2-hydroxyethyl)-5-oxooxazolidine-3-carboxylate in a suitable solvent, adding sulfonyl chloride dropwise under the catalysis of a base, and then washing with alkali, washing with water, drying, and concentrating to obtain compound I; the solvent includes dichloromethane, chloroform, DMF, DMSO, ethyl acetate, toluene, xylene, cyclohexane, acetonitrile, ethanol, isopropanol, and methanol.
- 一种L-草铵膦的制备方法,其特征在于,在于使用权利要求1所述的化合物I或者根据权利要求2所述的制备方法得到的化合物I为原料进行制备得到,所述制备方法包括如下步骤:A method for preparing L-glufosinate ammonium, characterized in that the compound I according to claim 1 or the compound I obtained by the preparation method according to claim 2 is used as a raw material for preparation, and the preparation method comprises the following steps:S1:将化合物I与化合物II按照一定比例,在合适的溶剂下进行缩合反应得到化合物III,其化学反应式为:
S1: Compound I and compound II are subjected to condensation reaction in a certain ratio in a suitable solvent to obtain compound III, the chemical reaction formula of which is:
S2:将上述得到的化合物III在酸存在下经过水解脱保护基而制得L-草铵膦,其化学反应式为:
S2: The compound III obtained above is subjected to hydrolysis in the presence of an acid to deprotect the group to obtain L-phosphinothricin ammonium, and the chemical reaction formula is:
- 根据权利要求3所述的L-草铵膦的制备方法,其特征在于,步骤S1中所述化合物II为甲亚磷酸酯,其结构式如下:
The method for preparing L-glufosinate according to claim 3, characterized in that the compound II in step S1 is methylphosphite, and its structural formula is as follows:
其中,R3为甲基,乙基,丙基,异丙基,正丁基,叔丁基。Among them, R3 is methyl, ethyl, propyl, isopropyl, n-butyl, tert-butyl. - 根据权利要求3所述的L-草铵膦的制备方法,其特征在于,步骤S1中所述化合物I和化合物II的物质量比为1:1-100。The method for preparing L-glufosinate according to claim 3, characterized in that the amount ratio of compound I and compound II in step S1 is 1:1-100.
- 根据权利要求3所述的L-草铵膦的制备方法,其特征在于,步骤S1中所述溶剂按照与化合物I的质量比为0.1-100:1加入,优选地,质量比为5-10:1。The method for preparing L-glufosinate according to claim 3, characterized in that the solvent in step S1 is added in a mass ratio of 0.1-100:1 to compound I, preferably, the mass ratio is 5-10:1.
- 根据权利要求3所述的L-草铵膦的制备方法,其特征在于,步骤S1中所述溶剂选自由甲酸乙酯、乙酸乙酯、甲醇、乙醇、异丙醇、苯、甲苯、氯苯、二氯苯、硝基苯、二氯乙烷、氯仿、DMSO、DMF、HMPA、化合物II组成的组中的至少一种。The method for preparing L-glufosinate according to claim 3, characterized in that the solvent in step S1 is selected from at least one of the group consisting of ethyl formate, ethyl acetate, methanol, ethanol, isopropanol, benzene, toluene, chlorobenzene, dichlorobenzene, nitrobenzene, dichloroethane, chloroform, DMSO, DMF, HMPA, and compound II.
- 根据权利要求3所述的L-草铵膦的制备方法,其特征在于,步骤S1中所述缩合反应条件为:温度20~200℃,优选80-150℃,最优选90-110℃;时间1~24h,优选3-12h,最优选6-8h。 The method for preparing L-glufosinate according to claim 3, characterized in that the condensation reaction conditions in step S1 are: temperature 20-200° C., preferably 80-150° C., most preferably 90-110° C.; time 1-24 h, preferably 3-12 h, most preferably 6-8 h.
- 根据权利要求3所述的L-草铵膦的制备方法,其特征在于,步骤S2中所述酸选自由乙酸、三氟乙酸、三氟甲磺酸、盐酸、硫酸、甲磺酸、磷酸、氢氟酸、氢溴酸和氢碘酸组成的组中的至少一种。The method for preparing L-glufosinate according to claim 3, characterized in that the acid in step S2 is selected from at least one of the group consisting of acetic acid, trifluoroacetic acid, trifluoromethanesulfonic acid, hydrochloric acid, sulfuric acid, methanesulfonic acid, phosphoric acid, hydrofluoric acid, hydrobromic acid and hydroiodic acid.
- 根据权利要求3所述的L-草铵膦的制备方法,其特征在于,步骤S2中所述水解条件为:温度60-180℃,时间0.5-24h。 The method for preparing L-glufosinate according to claim 3, characterized in that the hydrolysis conditions in step S2 are: temperature 60-180° C., time 0.5-24 h.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310314143.9 | 2023-03-28 | ||
CN202310314143.9A CN118724833A (en) | 2023-03-28 | 2023-03-28 | Amino acid derivative, preparation method thereof and method for synthesizing L-glufosinate-ammonium as intermediate |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024198078A1 true WO2024198078A1 (en) | 2024-10-03 |
Family
ID=92844288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2023/097690 WO2024198078A1 (en) | 2023-03-28 | 2023-06-01 | Amino acid derivative, preparation method therefor, and method for synthesizing l-glufosinate ammonium using amino acid derivative as intermediate |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN118724833A (en) |
WO (1) | WO2024198078A1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5530142A (en) * | 1988-05-27 | 1996-06-25 | Hoechst Aktiengesellschaft | Process for the preparation of phosphorus-containing L-amino acids and their esters and N-derivatives |
WO2012074951A1 (en) * | 2010-11-29 | 2012-06-07 | OSI Pharmaceuticals, LLC | Macrocyclic kinase inhibitors |
CN107629046A (en) * | 2017-10-24 | 2018-01-26 | 青岛清原化合物有限公司 | Pyrazolone compound or its salt, herbicidal composition and purposes |
CN109369432A (en) * | 2018-11-02 | 2019-02-22 | 永农生物科学有限公司 | (S) preparation method of the chloro- 2-amino-butyric acid ester of -4- |
CN111662324A (en) * | 2019-03-05 | 2020-09-15 | 利尔化学股份有限公司 | Method for preparing L-glufosinate-ammonium |
WO2020242943A1 (en) * | 2019-05-29 | 2020-12-03 | Kallyope, Inc. | Gpr40 agonists |
CN113316580A (en) * | 2019-01-11 | 2021-08-27 | Cj第一制糖株式会社 | Preparation method of L-glufosinate-ammonium |
-
2023
- 2023-03-28 CN CN202310314143.9A patent/CN118724833A/en active Pending
- 2023-06-01 WO PCT/CN2023/097690 patent/WO2024198078A1/en unknown
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5530142A (en) * | 1988-05-27 | 1996-06-25 | Hoechst Aktiengesellschaft | Process for the preparation of phosphorus-containing L-amino acids and their esters and N-derivatives |
WO2012074951A1 (en) * | 2010-11-29 | 2012-06-07 | OSI Pharmaceuticals, LLC | Macrocyclic kinase inhibitors |
CN107629046A (en) * | 2017-10-24 | 2018-01-26 | 青岛清原化合物有限公司 | Pyrazolone compound or its salt, herbicidal composition and purposes |
CN109369432A (en) * | 2018-11-02 | 2019-02-22 | 永农生物科学有限公司 | (S) preparation method of the chloro- 2-amino-butyric acid ester of -4- |
CN113316580A (en) * | 2019-01-11 | 2021-08-27 | Cj第一制糖株式会社 | Preparation method of L-glufosinate-ammonium |
CN113316581A (en) * | 2019-01-11 | 2021-08-27 | Cj第一制糖株式会社 | L-glufosinate-ammonium intermediate and preparation method of L-glufosinate-ammonium |
CN111662324A (en) * | 2019-03-05 | 2020-09-15 | 利尔化学股份有限公司 | Method for preparing L-glufosinate-ammonium |
WO2020242943A1 (en) * | 2019-05-29 | 2020-12-03 | Kallyope, Inc. | Gpr40 agonists |
Non-Patent Citations (3)
Title |
---|
CHENG HENGMIAO, KEITZ PAUL, JONES J. BRYAN: "Design and Synthesis of a Conformationally Restricted Cysteine Protease Inhibitor", THE JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY, UNITED STATES, vol. 59, no. 25, 1 December 1994 (1994-12-01), United States, pages 7671 - 7676, XP093219055, ISSN: 0022-3263, DOI: 10.1021/jo00104a022 * |
ZEISS H-J: "ENANTIOSELECTIVE SYNTHESIS OF L PHOSPHINOTHRICIN FROM L METHIONINE AND L GLUTAMIC ACID VIA L VINYLGLYCINE", TETRAHEDRON, ELSEVIER SIENCE PUBLISHERS, AMSTERDAM, NL, vol. 48, no. 38, 1 January 1992 (1992-01-01), AMSTERDAM, NL , pages 8263 - 8270, XP002623488, ISSN: 0040-4020, DOI: 10.1016/S0040-4020(01)80494-4 * |
ZHUANG JIANYUAN, HU XIAO-XING: "Explore and Enlightenment on Foreign Industrialization Route of Glufosinate", NONGYAO, GAI-KAN BIANJIBU, SHENYANG, CN, vol. 53, no. 10, 1 October 2014 (2014-10-01), CN , pages 703 - 711, XP093219062, ISSN: 1006-0413, DOI: 10.16820/j.cnki.1006-0413.2014.10.002 * |
Also Published As
Publication number | Publication date |
---|---|
CN118724833A (en) | 2024-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111892507A (en) | Synthesis method of high-purity dopamine hydrochloride | |
US10934269B2 (en) | Process for preparation of apalutamide | |
CN114292231B (en) | 2-methyl-8-substituent-quinoline and preparation method thereof | |
US20130184490A1 (en) | Process to prepare s-2-hydroxy-3-methoxy-3,3-diphenyl propionic acid | |
WO2024198078A1 (en) | Amino acid derivative, preparation method therefor, and method for synthesizing l-glufosinate ammonium using amino acid derivative as intermediate | |
KR101539761B1 (en) | Method for preparing compounds through a novel Michael-addition reaction using water or various acids as additives | |
CN109265409B (en) | Synthesis method of 2-substituted benzoxazole, 2-substituted benzothiazole and derivatives thereof | |
CN102516133A (en) | Preparation method of methanesulfonic acid derivative | |
CN107868033B (en) | Preparation method of phenylalanine compound | |
WO2024198076A1 (en) | Amino acid derivative, preparation method therefor, and method for synthesizing l-glufosinate ammonium using amino acid derivative as intermediate | |
WO2024198077A1 (en) | Amino acid derivative and preparation method therefor, and method for using amino acid derivative as intermediate to synthesize l-glufosinate-ammonium | |
CN114315609A (en) | Process for preparing cis-2-aminocyclohexanol | |
CZ19099A3 (en) | Intermediates for preparing 2-imidazolin-5-ones | |
CN110256451B (en) | Synthetic method of benzofuro [2,3-b ] quinoline derivative | |
CN111848423B (en) | Preparation method of tert-butyl 3-oxocyclobutylcarbamate | |
KR100741620B1 (en) | Process for preparing amic acid esters | |
CN113336721A (en) | Chiral N-heterocyclic carbene catalyst and preparation method and application thereof | |
CN111039838B (en) | Preparation method of 3-acetylmercapto-2-methylpropanoic acid | |
US10807965B2 (en) | Process for preparation of apalutamide | |
CN113072471B (en) | Lifeiste intermediate and preparation method thereof | |
CN114213389B (en) | Synthesis method of benzo [ b ] naphtho [2,3-d ] thiophene | |
AU7235287A (en) | Synthesis of antiulcer compounds | |
US9303022B2 (en) | Industrial method for the preparation of high-purity methiozolin | |
CN110903238B (en) | Preparation method of kovar stat | |
JPH0377856A (en) | Production of optically active atenolol and its intermediate |